Telman Deborah H 4
4 · GILEAD SCIENCES, INC. · Filed Jul 28, 2025
Insider Transaction Report
Form 4
Telman Deborah H
EVP, Corporate Affairs & GC
Transactions
- Tax Payment
Common Stock
2025-07-25$116.20/sh−3,823$444,233→ 42,721 total - Exercise/Conversion
Common Stock
2025-07-25+514→ 38,315 total - Exercise/Conversion
Restricted Stock Unit
2025-07-25−514→ 29,875 total→ Common Stock (514 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-07-25−8,229→ 21,646 total→ Common Stock (8,229 underlying) - Exercise/Conversion
Common Stock
2025-07-25+8,229→ 46,544 total
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- [F3]The restricted stock units have a three-year vesting schedule. 33.33% will vest on each yearly anniversary of the date of the grant until fully vested.